Foundation directory
Collins Medical Trust Grants
Private foundation · EIN 93-6021895 · IRS 990-PF filings through tax year 2024
- Total grants paid
- $1.2M
- Grants reported
- 33
- Median grant
- $30K
- Future commitments
- None reported
Giving by tax year
| Tax year | Grants paid | Amount |
|---|---|---|
| 2024 | 15 | $575.7K |
| 2023 | 18 | $574.5K |
Where Collins Medical Trust gives
States of grant recipients reported on the foundation's 990-PF filings, by dollars received.
Oregon$1.2M
Largest reported grants
The biggest individual grants on file, as reported by the foundation to the IRS.
| Recipient | Location | Purpose | Tax year | Amount |
|---|---|---|---|---|
| LINFIELD COLLEGE - SCHOOL OF NURSING | MCMINNVILLE, OR | PAQUET NURSING SCHOLARSHIPS | 2023 | $65K |
| OHSU FOUNDATION | PORTLAND, OR | INVESTIGATING METABOLIC DISRUPTION IN MULTIPLE SCLEROSIS: VASCULAR DYSFUNCTION, MYELINATION FAILURE AND NEURODEGENERATION | 2024 | $40K |
| OHSU FOUNDATION | PORTLAND, OR | ESTABLISHING AN INTESTINAL EPITHELIAL ORGANOID PLATFORM FOR TISSUE-SCALE CRYO-ELECTRON TOMOGRAPHY | 2024 | $40K |
| OHSU FOUNDATION | PORTLAND, OR | ROLE OF COP9 SIGNALOSOME ON DISTAL CONVOLUTED TUBULE INJURY IN CISPLATIN-INDUCED NEPHROTOXICITY | 2024 | $40K |
| OHSU FOUNDATION | PORTLAND, OR | MODULARS OF GLP1R ACTIVITY FOLLOWING SEMAGLUTIDE-LIKE AGONISTS | 2024 | $40K |
| OHSU FOUNDATION | PORTLAND, OR | INTRACRANIAL ELECTRICAL FIELDS FOR THE TREATMENT OF GLIOBLASTOMA | 2024 | $40K |
| OHSU FOUNDATION | PORTLAND, OR | THE EFFECTS OF LONG-TERM IMMUNE CHECKPOINT BLOCKADE TREATMENT | 2024 | $40K |
| OHSU FOUNDATION | PORTLAND, OR | CHANGES IN THE METABOLOME IN PATIENTS WITH CIRRHOSIS AFTER TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT CREATION | 2024 | $40K |
| OHSU FOUNDATION | PORTLAND, OR | CHEMICAL PROBE MODULATION OF FOXP3 TO INHIBIT REGULATORY T-CELL IMMUNOSUPPRESSION | 2024 | $40K |
| PORTLAND VA RESEARCH FOUNDATION | PORTLAND, OR | PILOTING THE COGNITIVE AND ATTENTIONAL MASTERY PROGRAM AMONG VETERANS WITH PTSD | 2024 | $39.8K |
| OHSU FOUNDATION | PORTLAND, OR | NOVEL SPATIAL APPROACHES TO PINPOINT EPIGENTIC DETERMINANTS OF THERAPEUTIC ESCAPE IN BREAST CANCER | 2024 | $39.8K |
| OHSU FOUNDATION | PORTLAND, OR | OPTIMIZING MAMMOGRAPHIC SCREENING FOR WOMEN WITH DENSE BREAST TISSUE | 2024 | $39.4K |
| OHSU FOUNDATION | PORTLAND, OR | PLUMONARY VASCULAR REMODELING SECONDARY TO PULMONARY VENOUS OBSTRUCTION IN A FETAL SHEEP MODEL OF HYPOPLASTIC LEFT HEART SYNDROME | 2024 | $38.4K |
| OHSU FOUNDATION | PORTLAND, OR | EXAMINING FRACTURE AND OBSTETRIC COMPLICATION RATES IN THE PREGNANCY AND POST-PARTUM PERIOD IN WOMEN WITH OSTEOGENSIS IMPERFECTA | 2024 | $37K |
| OHSU FOUNDATION | PORTLAND, OR | MECHANISMS OF AUGMENTATION OF MR1 ANTIGEN PRESENTATION BY CFTR MODULATORS | 2024 | $36.3K |
| OHSU FOUNDATION | PORTLAND, OR | VOLUMETRIC BIOMARKERS TO PREDICT RETINOPATHY OF PREMATURITY PROGRESSION | 2023 | $30K |
| OHSU FOUNDATION | PORTLAND, OR | EFFECTS OF CDK 4/6 INHIBITION ON THE TUMOR MICROENVIROMENT OF METASTATIC BREAST CANCER | 2023 | $30K |
| OHSU FOUNDATION | PORTLAND, OR | ASSESSMENT OF CEFEPIME HETERORESISTANCE ACROSS PSEUDOMONAS AERUGINOSA BLOODSTREAM ISOLATES IN HEMATOLOGIC MALIGNANCY PATIENTS | 2023 | $30K |
| OHSU FOUNDATION | PORTLAND, OR | INVESTIGATING THE MODE OF ACTION OF CET-6D, A FIRST-IN-CLASS PIM-1 PROTEIN DEGRADER | 2023 | $30K |
| OHSU FOUNDATION | PORTLAND, OR | STRUCTURAL ANALYSIS OF CALMODULIN-MEDIATED RESPONSE IN ASTROCYTES TO TREAT CENTRAL NERVOUS SYSTEM EDEMA | 2023 | $30K |
| OHSU FOUNDATION | PORTLAND, OR | DETERMINING HOW SEX HORMONES TUNE THE B CELL RESPONSE TO RESPIRATORY VIRUS INFECTION | 2023 | $30K |
| OHSU FOUNDATION | PORTLAND, OR | EXPLORING THE DYNAMIC 3D GENOMIC LANDSCAPES IN BIALLELIC CEBPA MUTANT MYELOID MALIGNANCIES | 2023 | $30K |
| OHSU FOUNDATION | PORTLAND, OR | SLEEP AND CIRCADIAN EFFECTS OF AN ACUTE DOSE OF CBGA | 2023 | $30K |
| OHSU FOUNDATION | PORTLAND, OR | NATURAL KILLER LYMPHOCYTES AS DRIVERS OF KIDNEY INJURY DUE TO CARDIORENAL SYNDROME | 2023 | $30K |
| OHSU FOUNDATION | PORTLAND, OR | PEGYLATED-DRUGS FOR CONTROLLED RELEASE IN PRIMARY ENDONTONTIC INFECTIONS | 2023 | $30K |
How to apply
This foundation publishes application instructions on its latest 990-PF and does not report restricting giving to preselected organizations. See more foundations that accept applications.
- Contact
- TAMARA POTRUCH
- Address
- 29100 SW TOWN CENTER LOOP W SUITE 300 WILSONVILLE, OR, 97070
- Phone
- 5038265230
- CMT@COLLINSMEDICALTRUST.ORG
- Deadlines
- NONE
- Application materials
- LETTER DESCRIBING PROJECT, FUNDS NEEDED, TAX EXEMPT STATUS
- Restrictions
- LIMITED TO MEDICAL EDUCATION AND RESEARCH IN OREGON
About this data
Figures are aggregated from Collins Medical Trust's IRS Form 990-PF electronic filings (2 filings on file, most recent tax year 2024). Totals reflect grants the foundation reported as paid, and can lag the current year because foundations file annually and often on extension. Source: IRS 990-PF e-file archive.